The 5 training gaps we consistently find in market access field teams
What training gaps hold back market access field teams? We see the same five gaps show up…
What training gaps hold back market access field teams? We see the same five gaps show up account after account, and none of them close with more content. The most costly is process training that isn’t mapped to the patient journey, which leaves field reimbursement managers (FRMs) unsure who owns a prior authorization denial when a launch goes live. This one pager covers all five gaps, what each one looks like in the field, and the training approach that prepares a field access team for the conversations it will actually have.
What training gaps hold back market access field teams? We see the same five gaps show up…
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
When launch budgets shrink, training priorities become even more important. This one-pager outlines a practical framework for…
Most pharma launches fail not because the science is wrong, but because the people delivering it are…